Skip to content
PubMed This is a summary of 39 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 39 referenced papers

Top Authors

Tilmann Kallinich
Leibniz Association
Seza Özen
Hacettepe University
Marco Gattorno
Istituto Giannina Gaslini
Sophie Georgin‐Lavialle
Sorbonne Université
Dirk Foell
University of Münster
Kirsten Minden
Humboldt-Universität zu Berlin
Özgür Kasapçopur
Istanbul University-Cerrahpaşa
Alexandre Bélot
Lyon 1 Université
Sulaiman Mohammed Al-Mayouf
Alfaisal University
Helen Jane Lachmann
Royal Free London NHS Foundation Trust

Top Institutions

Ranked by publications Top 10 institutions
02

Leibniz Association

Berlin, Germany

16 papers
08

University of Münster

Münster, Germany

27 papers
09

Humboldt-Universität zu Berlin

Berlin, Germany

17 papers

References

References (39)
  1. 1

    Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.

    Kallinich T, Thorwarth A, von Stuckrad SL, et al.

    Pediatric rheumatology online journal 2016; (14(1)):63 doi:10.1186/s12969-016-0124-2.

    PMID: 27881174
  2. 2

    Juvenile Idiopathic Arthritis.

    Barut K, Adrovic A, Şahin S, Kasapçopur Ö

    Balkan medical journal 2017; (34(2)):90-101 doi:10.4274/balkanmedj.2017.0111.

    PMID: 28418334
  3. 3

    Proteinuria in children with juvenile idiopathic arthritis: Making the case for early urinary screening.

    Saha A, Pais P, Iyengar AA, Abraham AK

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2017; (28(6)):1408-1411 doi:10.4103/1319-2442.220854.

    PMID: 29265055
  4. 4

    Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

    Hinze CH, Holzinger D, Lainka E, et al.

    Pediatric rheumatology online journal 2018; (16(1)):7 doi:10.1186/s12969-018-0224-2.

    PMID: 29357887
  5. 5

    Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.

    Ferrara G, Pastore S, Sancin L, et al.

    The Journal of rheumatology 2018; (45(10)):1418-1421 doi:10.3899/jrheum.171200.

    PMID: 29907671
  6. 6

    Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

    de Zegher F, Reynaert N, De Somer L, et al.

    Hormone research in paediatrics 2018; (90(5)):337-343 doi:10.1159/000489778.

    PMID: 29940586
  7. 7

    Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.

    Ter Haar NM, van Dijkhuizen EHP, Swart JF, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(7)):1163-1173 doi:10.1002/art.40865.

    PMID: 30848528
  8. 8

    2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

    Angeles-Han ST, Ringold S, Beukelman T, et al.

    Arthritis care & research 2019; (71(6)):703-716 doi:10.1002/acr.23871.

    PMID: 31021540
  9. 9

    A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.

    Özen S, Batu ED, Taşkıran EZ, et al.

    The Journal of rheumatology 2020; (47(1)):117-125 doi:10.3899/jrheum.181384.

    PMID: 31043544
  10. 10

    Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.

    Barut K, Adrovic A, Sahin S, et al.

    International journal of rheumatic diseases 2019; (22(9)):1661-1669 doi:10.1111/1756-185X.13649.

    PMID: 31273940
  11. 11

    PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.

    Maggio MC, Ceccherini I, Grossi A, et al.

    Italian journal of pediatrics 2019; (45(1)):111 doi:10.1186/s13052-019-0705-z.

    PMID: 31443670
  12. 12

    Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).

    Al-Mayouf SM, Almutairi A, Albrawi S, et al.

    Rheumatology international 2020; (40(1)):49-56 doi:10.1007/s00296-019-04478-3.

    PMID: 31741047
  13. 13

    LACC1 Required for NOD2-Induced, ER Stress-Mediated Innate Immune Outcomes in Human Macrophages and LACC1 Risk Variants Modulate These Outcomes.

    Huang C, Hedl M, Ranjan K, Abraham C

    Cell reports 2019; (29(13)):4525-4539.e4 doi:10.1016/j.celrep.2019.11.105.

    PMID: 31875558
  14. 14

    ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.

    Shinar Y, Ceccherini I, Rowczenio D, et al.

    Clinical chemistry 2020; (66(4)):525-536 doi:10.1093/clinchem/hvaa024.

    PMID: 32176780
  15. 15

    A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity.

    Butbul Aviel Y, Ofir A, Ben-Izhak O, et al.

    Rheumatology (Oxford, England) 2021; (60(10)):4888-4898 doi:10.1093/rheumatology/keab017.

    PMID: 33493343
  16. 16

    LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages.

    Omarjee O, Mathieu AL, Quiniou G, et al.

    The Journal of experimental medicine 2021; (218(3)) doi:10.1084/jem.20201006.

    PMID: 33606008
  17. 17

    New or vanishing frontiers: LACC1-associated juvenile arthritis.

    Al-Mayouf SM, Yateem M, Al-Dusery H, et al.

    International journal of pediatrics & adolescent medicine 2021; (8(1)):44-47 doi:10.1016/j.ijpam.2020.11.005.

    PMID: 33718577
  18. 18

    Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis.

    Lazăr C, Spîrchez M, Ştefan M, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S28-S32 doi:10.15386/mpr-2224.

    PMID: 34527905
  19. 19

    Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil.

    Fernandes SJ, Valdomir Nadaf MI, Monteiro NH, et al.

    Case reports in immunology 2021; (2021()):6660937 doi:10.1155/2021/6660937.

    PMID: 34938582
  20. 20

    Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.

    Kafle R, Bhatta A, Gami S, et al.

    JNMA; journal of the Nepal Medical Association 2021; (59(243)):1166-1169 doi:10.31729/jnma.7019.

    PMID: 35199753
  21. 21

    Efficacy and safety of tofacitinib in the treatment of refractory cases of polyarticular course juvenile idiopathic arthritis: A study from Bangladesh.

    Rahman MM, Laila K, Rahman SA

    International journal of rheumatic diseases 2022; (25(6)):678-684 doi:10.1111/1756-185X.14324.

    PMID: 35435319
  22. 22

    Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience.

    Høeg PE, Glerup M, Mahler B, et al.

    International journal of rheumatology 2022; (2022()):1784529 doi:10.1155/2022/1784529.

    PMID: 35936656
  23. 23

    A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.

    Leinonen S

    Acta ophthalmologica 2023; (101(4)):465-468 doi:10.1111/aos.15299.

    PMID: 36458735
  24. 24

    Systematic genetic analysis of pediatric patients with autoinflammatory diseases.

    Poker Y, von Hardenberg S, Hofmann W, et al.

    Frontiers in genetics 2023; (14()):1065907 doi:10.3389/fgene.2023.1065907.

    PMID: 36777733
  25. 25

    Nutritional Aspects of Juvenile Idiopathic Arthritis: An A to Z for Dietitians.

    Grammatikopoulou MG, Gkiouras K, Syrmou V, et al.

    Children (Basel, Switzerland) 2023; (10(2)) doi:10.3390/children10020203.

    PMID: 36832332
  26. 26

    Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review.

    Wu Y, Wang S, Yin W, et al.

    Molecular genetics & genomic medicine 2023; (11(7)):e2175 doi:10.1002/mgg3.2175.

    PMID: 37186377
  27. 27

    [Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].

    Knieper AM, von Stuckrad ASL, Minden K, et al.

    Zeitschrift fur Rheumatologie 2024; (83(1)):4-14 doi:10.1007/s00393-023-01442-2.

    PMID: 37921883
  28. 28

    Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.

    Scagnellato L, Cozzi G, Prosepe I, et al.

    PloS one 2024; (19(5)):e0298679 doi:10.1371/journal.pone.0298679.

    PMID: 38696444
  29. 29

    The cultural differences in transition assessment: Evaluation of TRANSITION-Q and STARx scales on Turkish rheumatic patients.

    Yiğit RE, Çağlayan Ş, Sözeri B

    Archives of rheumatology 2024; (39(2)):255-264 doi:10.46497/ArchRheumatol.2024.10379.

    PMID: 38933719
  30. 30

    LACC1 deficiency leading to juvenile arthritis and anemia.

    He T, Wang L, Huang X, et al.

    Clinical immunology (Orlando, Fla.) 2024; (265()):110290 doi:10.1016/j.clim.2024.110290.

    PMID: 38944365
  31. 31

    Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease.

    Özçelik E, Çelikel E, Tekin ZE, et al.

    Journal of paediatrics and child health 2024; (60(10)):511-515 doi:10.1111/jpc.16623.

    PMID: 39051573
  32. 32

    A child with systemic onset juvenile idiopathic arthritis and nephrotic syndrome.

    Singhal JS, Pande N, Sharma J

    Pediatric nephrology (Berlin, Germany) 2025; (40(2)):381-383 doi:10.1007/s00467-024-06495-2.

    PMID: 39249127
  33. 33

    EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update.

    Ozen S, Sağ E, Oton T, et al.

    Annals of the rheumatic diseases 2025; (84(6)):899-909 doi:10.1016/j.ard.2025.01.028.

    PMID: 40234174
  34. 34

    French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease.

    Quartier P, Belot A, Breton S, et al.

    La Revue de medecine interne 2025; (46(8)):449-481 doi:10.1016/j.revmed.2025.06.001.

    PMID: 40544011
  35. 35

    A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.

    Alblooshi H, Mustafa N, Khalam AA, et al.

    Human genomics 2025; (19(1)):85.

    PMID: 40713900
  36. 36

    Clinical and genetic analysis of Majeed syndrome caused by LPIN2 complex heterozygous mutation and literature review.

    Wang S, Yu T, He X, et al.

    Frontiers in pediatrics 2025; (13()):1602509 doi:10.3389/fped.2025.1602509.

    PMID: 41113563
  37. 37

    Pan American League of Associations for Rheumatology treatment recommendations for systemic juvenile idiopathic arthritis.

    Franco L, Rodrigues Fonseca A, Barzola ML, et al.

    Rheumatology advances in practice 2025; (9(4)):rkaf087 doi:10.1093/rap/rkaf087.

    PMID: 41234672
  38. 38

    Sleep Quality and Depressive Symptoms in Clinically Stable Pediatric Familial Mediterranean Fever: Associations with Disease Severity and Developmental Factors.

    Baris Cetinkaya B, Battal F

    Children (Basel, Switzerland) 2026; (13(7)) doi:10.3390/children13070950.

    PMID: 42509975
  39. 39

    Psychosocial burden in pediatric familial mediterranean fever: A study of quality of life, sleep habits, maternal mental health, and clinical correlates.

    Taşkın SN, Karaca Ahat T, Bozkaya Yücel B, et al.

    BMC psychology 2026; (14(1)).

    PMID: 42773465